Results
637
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
637 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
RHM | €889.60 | 17.5% | 121.5% | €38.6b | €862.93 | PE56.4x | E30.5% | 0.6% | Capital Goods | ||
ARES | US$179.69 | -2.5% | 34.1% | US$58.5b | US$198.57 | PE82.3x | E41.4% | 2.5% | Diversified Financials | ||
NVDA | US$140.11 | 0.9% | 77.8% | US$3.4t | US$172.22 | PE54.4x | E21.6% | 0.03% | Semiconductors | ||
ONON | US$51.21 | -2.2% | 58.7% | US$16.7b | US$63.72 | PE116.8x | E30.2% | n/a | Consumer Durables | ||
ALNY | US$251.00 | -5.2% | 54.2% | US$32.4b | US$301.27 | PS14.5x | E59.1% | n/a | Pharmaceuticals & Biotech | ||
600760 | CN¥45.90 | -0.9% | 19.6% | CN¥125.1b | CN¥53.90 | PE51.4x | E29.4% | 0.6% | Capital Goods | ||
9992 | HK$108.10 | -2.4% | 437.8% | HK$138.7b | HK$101.68 | PE87.6x | E36.8% | 0.3% | Retail | ||
6181 | HK$548.50 | 11.3% | n/a | HK$78.9b | HK$483.34 | PE106.7x | E41.3% | n/a | Consumer Durables | ||
NU | US$13.34 | -3.3% | 28.8% | US$64.8b | US$15.04 | PB8.4x | E24.9% | n/a | Banks | ||
300308 | CN¥118.73 | 10.5% | 12.5% | CN¥126.4b | CN¥192.85 | PE28.3x | E33.3% | 0.3% | Tech | ||
ALAB | US$88.43 | 0.3% | n/a | US$14.6b | US$124.53 | PS36.2x | E61.3% | n/a | Semiconductors | ||
2382 | NT$269.50 | 3.7% | 11.8% | NT$1.0t | NT$358.05 | PE19.2x | E20.8% | 3.3% | Tech | ||
300502 | CN¥121.04 | 11.0% | 101.9% | CN¥84.5b | CN¥161.36 | PE45x | E36.6% | 0.1% | Tech | ||
A012450 | ₩654,000.00 | 22.7% | 282.1% | ₩29.3t | ₩614,150.00 | PE44x | E30.0% | 0.3% | Capital Goods | ||
2345 | NT$714.00 | -1.5% | 34.2% | NT$394.6b | NT$870.00 | PE41x | E33.7% | 1.4% | Tech | ||
A196170 | ₩392,000.00 | -0.5% | 198.8% | ₩20.1t | ₩565,000.00 | PS280.9x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$104.00 | -4.8% | 3.9% | US$19.8b | US$132.85 | PE10.2x | E20.8% | 6.5% | Diversified Financials | ||
ITCI | US$128.54 | 0.4% | 78.7% | US$13.7b | US$132.73 | PS22.3x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
BAM | CA$85.50 | 4.7% | 52.2% | CA$139.2b | CA$74.71 | PE180x | E67.5% | 2.9% | Diversified Financials | ||
SMCI | US$59.27 | 40.2% | -39.2% | US$35.3b | US$47.52 | PE28.7x | E27.6% | n/a | Tech | ||
PME | AU$285.81 | 0.8% | 191.0% | AU$29.9b | AU$254.50 | PE303.9x | E23.6% | 0.2% | Healthcare | ||
600989 | CN¥15.70 | -5.5% | 6.1% | CN¥116.6b | CN¥21.74 | PE18.3x | E38.5% | 1.8% | Materials | ||
SYM | US$26.09 | -5.9% | -34.2% | US$15.7b | US$34.32 | PS1.5x | E84.6% | n/a | Capital Goods | ||
BAJFINANCE | ₹8,399.45 | -0.1% | 25.8% | ₹5.2t | ₹8,665.33 | PE32.5x | E23.3% | 0.4% | Diversified Financials |